Case Study and Suggested Protocols for Integrative Approaches to Treatment of Multiple Sclerosis

Multiple Sclerosis (MS) refers to a complicated autoimmune disorder that characteristically targets adults in their 20’s or 40’s. As stated by Ghaiad [1]. It is the most prevalent disabling neurological disorder among this age group. It results from an abnormal reaction by immune cells that should protect the system against infection. Sclerosis is revealed to be evident in MRI as a result of this autoimmune attack. People may have different symptomatology and clinical courses of the disease as it is a polymorphic entity. Some symptoms associated with MS, particularly when experienced together, can be severe and affect different facets of life for the affected patients. As Sharrack indicated, these manifestations are determined by the intensity and position of the inflammatory response and the amount of deposit build-up [2]. MS attacks the axons in the central nervous system, simultaneously damaging the white and gray matter. In a later stage of the disease, patients experience cortical atrophy that leads to a loss of the outermost component of the brain, i.e., the cerebral cortex [3]. These include symptoms that are characterized by bodily disabilities such as muscle weakness, spasms, or paralysis, as well as tactile disturbances like tingling or pain.

Authors

Publication Details

Journal
Clinical and Medical Engineering Live
Published
2024-11-20
DOI
https://doi.org/10.64030/2997-612x.02.03.03
Primary Topic
Biotechnology and Related Fields
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Case Study and Suggested Protocols for Integrative Approaches to Treatment of Multiple Sclerosis

Christina Rahm
Clinical and Medical Engineering Live
Biotechnology and Related Fields
article

Case Study and Suggested Protocols for Integrative Approaches to Treatment of Multiple Sclerosis

Christina Rahm
article en

Abstract

Multiple Sclerosis (MS) refers to a complicated autoimmune disorder that characteristically targets adults in their 20’s or 40’s. As stated by Ghaiad [1]. It is the most prevalent disabling neurological disorder among this age group. It results from an abnormal reaction by immune cells that should protect the system against infection. Sclerosis is revealed to be evident in MRI as a result of this autoimmune attack. People may have different symptomatology and clinical courses of the disease as it is a polymorphic entity. Some symptoms associated with MS, particularly when experienced together, can be severe and affect different facets of life for the affected patients. As Sharrack indicated, these manifestations are determined by the intensity and position of the inflammatory response and the amount of deposit build-up [2]. MS attacks the axons in the central nervous system, simultaneously damaging the white and gray matter. In a later stage of the disease, patients experience cortical atrophy that leads to a loss of the outermost component of the brain, i.e., the cerebral cortex [3]. These include symptoms that are characterized by bodily disabilities such as muscle weakness, spasms, or paralysis, as well as tactile disturbances like tingling or pain.

Clinical and Medical Engineering LiveVol. 2(3)
Openalex Percentile: Top 58%
Biotechnology and Related Fields
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.